[HTML][HTML] Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation

I Abboud, R Porcher, M Robin, RP de Latour… - Biology of Blood and …, 2009 - Elsevier
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a
wide range of diseases, but is associated with a significant risk of chronic kidney disease …

Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.

I Abboud, R Porcher, M Robin… - Biology of Blood and …, 2009 - europepmc.org
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a
wide range of diseases, but is associated with a significant risk of chronic kidney disease …

[引用][C] Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation

I ABBOUD - Biol Blood Marrow Transplant, 2009 - cir.nii.ac.jp
Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic
hematopoietic stem cell transplantation | CiNii Research CiNii 国立情報学研究所 学術情報 …

[HTML][HTML] Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation

I Abboud, R Porcher, M Robin, RP de Latour… - Biology of Blood and …, 2009 - tctjournal.org
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a
wide range of diseases, but is associated with a significant risk of chronic kidney disease …

Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation

I Abboud, R Porcher, M Robin… - Biology of blood …, 2009 - pubmed.ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a
wide range of diseases, but is associated with a significant risk of chronic kidney disease …

[PDF][PDF] Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation

I Abboud, R Porcher, M Robin… - Biol Blood Marrow …, 2009 - cyberleninka.org
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for a wide
range of hematologic, neoplastic, immunologic, and metabolic diseases. It has improved the …

[HTML][HTML] Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation

I Abboud, R Porcher, M Robin… - Biology of Blood and …, 2009 - astctjournal.org
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a
wide range of diseases, but is associated with a significant risk of chronic kidney disease …

[PDF][PDF] Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation

I Abboud, R Porcher, M Robin, RP de Latour… - Biol Blood Marrow …, 2009 - core.ac.uk
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for a wide
range of hematologic, neoplastic, immunologic, and metabolic diseases. It has improved the …

Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation

I Abboud, R Porcher, M Robin, RP de Latour… - Biology of Blood and …, 2009 - infona.pl
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a
wide range of diseases, but is associated with a significant risk of chronic kidney disease …

[PDF][PDF] Chronic Kidney Dysfunction in Patients Alive without Relapse 2 Years after Allogeneic Hematopoietic Stem Cell Transplantation

I Abboud, R Porcher, M Robin… - Biol Blood Marrow …, 2009 - scholar.archive.org
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for a wide
range of hematologic, neoplastic, immunologic, and metabolic diseases. It has improved the …